TrialCirculation2024

Dapagliflozin Enhances Arterial and Venous Compliance During Exercise in Heart Failure With Preserved Ejection Fraction: Insights From the CAMEO-DAPA Trial.

Atsushi Tada et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.